Literature DB >> 1866563

Use of granulocyte-macrophage colony stimulating factor for treatment of drug-induced agranulocytosis.

F R Wallach, J Zirn, H W Murray, J Tepler, N M Luger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1866563     DOI： 10.1093/clinids/13.3.523

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN： 0162-0886


× No keyword cloud information.
  2 in total

1.  Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).

Authors:  A Willfort; C Lorber; S Kapiotis; S Sertl; R Hainz; P Kirchweger; U Jäger; P A Kyrle; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

2.  Risks of rhG-CSF treatment in drug-induced agranulocytosis.

Authors:  H Demuynck; P Zachée; G E Verhoef; M Schetz; G Van den Berghe; P Lauwers; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.